Posted by Michael Wonder on 29 Nov 2023
Foslevodopa with foscarbidopa for the treatment of patients with advanced Parkinson’s with motor symptoms
29 November 2023 - NICE has published final evidence-based recommendations on the use of foslevodopa with foscarbidopa (Produodopa) for the treatment of adults with advanced Parkinson’s with motor symptoms.
Foslevodopa with foscarbidopa is recommended as an option for the treatment of adults with advanced levodopa-responsive Parkinson's whose symptoms include severe motor fluctuations and hyperkinesia or dyskinesia, when available medicines are not working well enough, only if they cannot have apomorphine or deep brain stimulation, or these treatments no longer control symptoms.
